Establishing medical plausibility in the context of orphan medicines designation in the European Union.
Open Access
- 5 December 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 9 (1), 175
- https://doi.org/10.1186/s13023-014-0175-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Medical and dental management of Alagille syndrome: A reviewMedical Science Monitor, 2014
- Animal models for metabolic, neuromuscular and ophthalmological rare diseasesNature Reviews Drug Discovery, 2013
- Evaluation and treatment of the newborn with epidermolysis bullosaSeminars in Perinatology, 2013
- Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type CDisease Models & Mechanisms, 2013
- Recurrence of hepatitis C after liver transplantation2013
- Alagille syndrome: pathogenesis, diagnosis and managementEuropean Journal of Human Genetics, 2011
- Eosinophilic esophagitis: Updated consensus recommendations for children and adultsJournal of Allergy and Clinical Immunology, 2011
- Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiencyStem Cells and Cloning: Advances and Applications, 2009
- Fragile X syndrome: from molecular genetics to therapyJournal of Medical Genetics, 2009
- Clinical, Electrophysiological, and Serum Biochemical Measures of Progressive Neurological and Hepatic Dysfunction in Feline Niemann-Pick Type C DiseasePediatric Research, 2008